Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Journal notices
Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries
Curated by Giuseppe Giaccone (Cornell) and Sharon Pine (Univ. of Colorado), this collection showcases key advances in thoracic oncology: cancer biology, diagnostics, treatments, biomarkers, translational insights, early detection, and clinical care.
Research Spotlight: Mechanisms and Technologies in Cancer Epigenetics
A tour of how DNA methylation, histone marks, chromatin remodeling, and non-coding RNAs shape tumors, plus tools like single-cell and multi-omics profiling, spatial epigenomics, long-read sequencing, and CRISPR-based epigenome editing.
ESMO AI and Digital Oncology Congress 2025 in Berlin
We will attend the ESMO AI and Digital Oncology Congress in Berlin, 12–14 November 2025. Clinicians, researchers, and health leaders will share practical work to improve cancer diagnosis and care. We look forward to seeing you there.
Editor’s Pick: ERα and GPER in Therapy Resistance
From receptor biology to resistance, this review charts ERα/ERβ and GPER signaling, ESR1 hotspot mutations that stabilize agonist states and fuel endocrine resistance, and new therapies aimed at ERα mutants and GPER.
"From Virtual to Reality: the Future of Surgery" Congress, Treviso 2025
We are proud to sponsor a surgery-focused congress in Treviso, led by our Surgical Oncology Specialty Chief Editor, Dr. Francesco Giovinazzo. The program highlights advances in surgical oncology, minimally invasive care, robotics, AI, and AR.
Editors
See allmassimo broggini
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Specialty Chief Editor
Cancer Molecular Targets and Therapeutics
brian d adams
Brain Institute of America
New Haven, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
vaishali aggarwal
Department of Immunology, School of Medicine, University of Pittsburgh
Pittsburgh, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
nemat ali
King Saud University
Riyadh, Saudi Arabia
Associate Editor
Cancer Molecular Targets and Therapeutics
